The Case for Security in Bioinformatics



By Christopher Frenz

April 12, 2007 |  In the past two decades, connectivity to networked resources has transformed the way that businesses and retailers operate.  As in the business world, the bioinformatics arena is reveling in electronic data exchange. PubMed boasts more than 16 million biomedical abstracts, and GenBank houses more than 61 million biological sequences.

In addition to networked data repositories, there are a plethora of web applications (e.g. BLAST search tool), and applications for calculating everything from amino-acid ionization states (e.g. H++) to identifying protein domains (e.g. SMART). The Web helps disseminate bioinformatics software, much of it open source, through sites such as Bioinformatics.org and SourceForge.

The prevalence of distribution of scientific data and tools is invaluable to researchers, but despite their vulnerability to the same potential threats that plague their commercial counterparts, security is rarely discussed in the bioinformatics community.

Should developers or distributors of bioinformatics applications be required to make security considerations an essential element of their development or hosting process? While there have been no reports of widespread abuse of scientific computing resources to date, the potential for such abuses do exist.

Threat Assessment
The strict integration of security within bioinformatics application development (including hosted databases) complicates the process, adding time to development and potentially its availability (in extreme cases security concerns can halt release). Moreover, accessing certain data sets or interacting with certain utilities may be complicated to ensure that security measures are properly met. On the user end, time and effort must be spent to evaluate the safety of utilizing a utility rather than just implicitly trusting the utility. These security considerations can interfere with or compete with scientific research for available resources. But what could happen if security measures are not tightly integrated into our application development efforts and usage?

A major threat for Web databases and applications is Denial of Service (DoS) attacks, which render networked resources unavailable to users. Such attacks could seriously hamper research efforts, particularly as many bioinformatics utilities use Web services or API to access content, and a failure to retrieve such content could interfere with an entire application pipeline. 

While DoS attacks are not uncommon, scientific databases are subject to more insidious attacks such as submission of, or change of a record to faulty information (Web database) or the malicious return of faulty results (Web application). The hidden presence of faulty records can waste both time and money, while a Web application security breach could hinder research. When dealing with medical applications, the stakes could be even higher. 

Furthermore, pharming scams could be applied to hosted bioinformatics databases and applications, where detailed logging of user requests and data submissions could potentially be used as a form of industrial espionage. By closely monitoring submitted data and requests along with IP addresses, it could be possible to gain insights into the research activities of other laboratories.

Web-based hosting and distribution of source code and executables introduces important security considerations, including the possibility that an application may be used as a Trojan horse, a malicious purpose concealed behind some seemingly useful functionality. This malicious functionality could damage files or applications or be used for espionage by sending data located on the computer or entered into the application to a remote site.

Here the open source nature of much bioinformatics application development offers both advantages and disadvantages. The ability for anyone to read the code associated with the application can make such breaches easier to spot, but the community-based approach to development can also facilitate such breaches into the application source, since a security flaw could be added by the incorporation of a submitted patch or enhancement.  

Potential security breaches introduced by application installation need not be malicious; numerous applications have been released that contained inadvertent security exploits, such as buffer overflows. Thus bioinformatics applications could introduce similar security vulnerabilities, particularly when developers do not take the possibility into consideration. Users of bioinformatics software should evaluate any downloaded application for security exploits, intentional or not, before use. 

I would like to see the bioinformatics community establish a set of security-related guidelines for bioinformatics practitioners and software developers now, before such exploits become commonplace.

Such guidelines need not be drastically different from general information security recommendations. The key would be to find the proper balance between time and resources spent implementing security and that spent advancing the scientific body of knowledge.

Christopher Frenz is at the Dept. Computer Engineering Technology, New York City College of Technology, Brooklyn, New York. Email: cfrenz@gmail.com.

Subscribe to Bio-IT World  magazine.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .